Self-amplifying RNA vaccines for infectious diseases

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla‐Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,810

Key roles of adjuvants in modern vaccines

Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,478

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127

DNA vaccines: ready for prime time?

Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077

Reversible methylation of m6Am in the 5′ cap controls mRNA stability

Mauer, J., Luo, X., Blanjoie, A., Jiao, X., Grozhik, A. V., Patil, D. P., Linder, B., Pickering, B. F., Vasseur, J., Chen, Q., et al. (2016) · Nature · doi:10.1038/nature21022 · Cited by 1,072

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066

2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members

Daffis, S., Szretter, K. J., Schriewer, J. M., Li, J., Youn, S., Errett, J. S., Lin, T., Schneller, S. W., Züst, R., Dong, H., et al. (2010) · Nature · doi:10.1038/nature09489 · Cited by 910

Emerging lipid nanoparticle systems capable of efficient intramuscular RNA delivery

Raza, A., Zhang, R., Lu, R., Wen, J., & Wu, W. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2555507 · Cited by 7

Modern vaccine strategies for emerging zoonotic viruses

Ahmed, A., Safdar, M., Sardar, S., Yousaf, S., Farooq, F., Raza, A., Shahid, M., Malik, K. A., & Afzal, S. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2148660 · Cited by 6

Cell-Free Production Systems in Droplet Microfluidics

Sieskind, R., Cortajarena, A. L., & Manteca, A. (2023) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2023_224 · Cited by 5

Perspective vaccines for emerging viral diseases in farm animals

Allam, A. M., Elbayoumy, M. K., & Ghazy, A. A. (2023) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2023.12.3.179 · Cited by 6

Vaccinomics: Paving the Way for Personalized Immunization

AL-Eitan, L. N., ElMotasem, M. F. M., Khair, I. Y., & Alahmad, S. Z. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128280417231204085137 · Cited by 5

pH-Responsive Micelles Containing Quinine Functionalities Enhance Intracellular Gene Delivery and Expression

Kreofsky, N. W., Roy, P., & Reineke, T. M. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00326 · Cited by 5

International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety

Robertson, J. S., Loizides‐Mangold, U., Adisa, A., Manjavacas, A. L. D. L. R., Rodilla, V., Strnadova, C., Weißer, K., & Balocco, R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.11.054 · Cited by 5

Recent Advances in mRNA Vaccine DevelopmentPreprint

Aga, A. M., Kelel, M., & Gemeda, M. T. (2023) · Preprints.org · doi:10.20944/preprints202308.0245.v1 · Cited by 5

Targeted suppression of type 1 interferon signaling during RNA delivery enhances vaccine-elicited immunityPreprint

Kim, B., Hosn, R. R., Remba, T. K., Dye, J., Mak, H. H., Jeong, J. Y., Cornwall-Brady, M. R., Abraham, W. D., Maiorino, L., Melo, M. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.09.642244 · Cited by 5

Artificial intelligence in precision mRNA therapeutics: Towards genomic language models and multi-agent virtual humans

Tan, T., Diao, Y., Yu, X., Chen, L., & Fang, H. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.044 · Cited by 8

Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease

O’Donnell, K. L., Anhalt, H., Saturday, G. A., Warner, N. L., Hinkley, T. C., Stone, E. T., Hatzakis, K., Khandhar, A. P., Banadyga, L., Erasmus, J. H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59560-1 · Cited by 4

Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms

Pazoki, A., Dadfar, S., Alirezaee, A., Oksenych, V., & Haghmorad, D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1617352 · Cited by 4

Augmented humoral responses to HIV Env trimers delivered as transmembrane immunogens by self-replicating RNA

Yousefpour, P., Ghosh, A. R., Chawla, H., Yeung, R., Gregory, J. R., Si, K., Remba, T. K., Rodrigues, K. A., Melo, M. B., Dye, J., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.07.036 · Cited by 4

RNA vaccines for cancer: revolutionizing immunization strategies

Huang, D., Zhang, J., Zeng, X., Zhang, Y., & Song, E. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.09.003 · Cited by 4

Engineered VPg saRNA achieves cap-independent, low-immunogenic and precise encoding of therapeutic proteins in vivo

Feng, Z., Chu, L., Li, Q., Zhou, J., Wu, P., Zhang, X., Pan, Y., Zou, J., Chen, Q., Xu, Z., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68364-w · Cited by 4

Delivery science: Its increasing importance for the next generation of medicines

Ashford, M. B., & Bak, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114663 · Cited by 5

Targeted cytosolic delivery of mRNA immunotherapeutics: From vaccine delivery to protein replacement

Chelan, E. M., Parhizkar, A., Nemati, M., Kiani, J., Almassian, B., Ghasemi, H., Zarebkohan, A., & Pourseif, M. M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119181 · Cited by 4

Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination

Galy, A. H. M., Berkhout, B., Breckpot, K., Pichon, C., Bloom, K. M., Kiem, H., Mühlebach, M. D., & McCune, J. M. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.123 · Cited by 4

Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models

Kachko, A. V., Selvaraj, P., Liu, S., Kim, J., Rotstein, D. S., Stauft, C. B., Chabot, S., Rajasagi, N. K., Zhao, Y., Wang, T. T., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.052 · Cited by 4

Delivery of Rna Drugs: Beyond the Liver, More than Vaccine

Elnaggar, M. G., He, Y., & Yeo, Y. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114203 · Cited by 4

Introduction to RNA Vaccines Post COVID-19

Kramps, T. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_1 · Cited by 4

Nanostrategies to Develop Current Antiviral Vaccines

Rodrigues, G. R., Sousa, M. G. D. C., da Silva, D. C., Rezende, T. M. B., Morais, P. C., & Franco, O. L. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01284 · Cited by 4

COVID-19 Infection and Response to Vaccination in Chronic Kidney Disease and Renal Transplantation: A Brief Presentation

Stai, S., Λιούλιος, Γ., Christodoulou, M., Kasimatis, E., Fylaktou, A., & Stangou, M. J. (2022) · Life · doi:10.3390/life12091358 · Cited by 4

Hospital-Based RNA Therapeutics

Damase, T. R., Sukhovershin, R. A., Zhang, M., Kiss, D., & Cooke, J. P. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_4 · Cited by 4

Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses

Guterres, A., Filho, P. N. S., & Moura‐Neto, V. (2024) · Vaccines · doi:10.3390/vaccines12010061 · Cited by 4

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?

Tournier, J., & Kononchik, J. P. (2021) · Viruses · doi:10.3390/v13040569 · Cited by 6

Next-Generation saRNA Platforms: Systematic Screening and Engineering Enhances Superior Protein Expression and Organ-Specific Targeting for RNA TherapeuticsPreprint

Sun, Z. F., Liu, Y., Zhang, H., Ge, T., Pan, Y., Liu, Y., Wu, M., Shan, T., Zhu, G., Wu, Q., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.30.644708 · Cited by 4

mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases

Tan, B. E. K., Tham, S. K., & Poh, C. L. (2025) · Viruses · doi:10.3390/v17070960 · Cited by 4

Comprehensive review on COVID-19: etiology, pathogenicity, and treatment

Zawily, A. E., Eckert, S., Adajar, R. C., Wagih, N., Elmaidomy, A. H., Helmy, A. M., Mustafa, M., Elshorbagi, M., Ghali, E., Fadl, R. G., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1569013 · Cited by 4

Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques

Styles, T. M., Akhtar, A., Gu, C., Neumann, G., Muramatsu, H., McPartlan, J. S., Talukder, P., Gratz, D., Stokdyk, K., Turner, H. L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102369 · Cited by 3

Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization

Ali, A. (2025) · Current Medical Science · doi:10.1007/s11596-025-00127-y · Cited by 4

Lipid nanoparticle–based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathways

Singh, N. S. S., Gataa, I. S., Saleh, L. H., Ganesan, S., Kavitha, V., Maharana, L., Sharma, R., Latipova, M., Madatova, N., Jumanazarov, D., et al. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04596-6 · Cited by 4

A versatile self-amplifying mRNA system consolidates oncolytic virus benefits into a single flexible backbone for cancer therapy

Hu, M., Li, Y., Cai, Y., He, X., Fan, J., Wang, J., Mu, Y., Shen, Y., Chen, J., Zhou, Q., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.066 · Cited by 3

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups

Matsuzaka, Y., & Yashiro, R. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040268 · Cited by 3

Localized Delivery of the mRNAs Encoding CD47 Inhibitor and Interleukins 12, 15, and 21 Elicits Robust Antitumor Immunity

Jiang, T., Jing, S., Li, H., Xiao, B., Jin, J., Sun, X., Wang, J., Liang, J., Cai, T., Hu, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202417205 · Cited by 3

A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City

Hernández-Hernández, V. A., Higuera-Iglesias, A. L., Palma-Cortés, G., Tapia‐Trejo, D., Ávila‐Ríos, S., González-Fernández, R. R., Pérez-Moreno, L. Á., Zúñiga, J., Guadarrama-Pérez, C., Sandoval‐Gutiérrez, J. L., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.029 · Cited by 3

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments

Wu, X., & Fang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1494887 · Cited by 4

Review on the bioanalysis of non-virus-based gene therapeutics

Zhou, M., Zhang, X., Yan, H., Xing, L., Yi, T., & Shen, L. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2437418 · Cited by 3

Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice

Park, J.-Y., Senevirathne, A., & Lee, J. H. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126524 · Cited by 2

Biological threat preparedness through vaccine development and stockpiling: challenges and strategic implications

Lee, J.-E. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1614626 · Cited by 2

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor

Chupin, C., Brun, P., Ray, M., Mialon, C., Reitano, M., Traversier, A., Laurent, E., Goumaidi, A., Fouret, J., Paul, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01231-9 · Cited by 3

Cascade amplification of therapeutic payloads for cancer immunotherapy

Li, Y., Wu, J., Li, N., Wu, M., Wang, Z., Li, J., & Zhang, L. (2025) · Communications Biology · doi:10.1038/s42003-025-08735-z · Cited by 2

Pioneering next-generation mRNA therapeutics through molecular engineering and delivery optimization

Qi, L., Li, Z., Feng, Z., Liu, J., & Chen, X. S. (2025) · Materials Today · doi:10.1016/j.mattod.2025.08.023 · Cited by 3

RNA-based cancer vaccines: mechanisms, clinical progress, and translational challenges

Al‐Kabariti, A. Y., Kadhim, M. A., Mousa, H. M., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., & Chauhan, A. S. (2025) · Immunologic Research · doi:10.1007/s12026-025-09725-3 · Cited by 2

Optimizing Humoral Immunity for Durable and Broad Protection in Flavivirus Vaccines

Park, J. Y., & Lee, H. (2025) · Vaccines · doi:10.3390/vaccines13121182 · Cited by 2

A novel alphavirus-based saRNA platform for enhanced vaccination efficacy and organ-specific targeting

Sun, Z. F., Liu, Y., Zhang, H., Ge, T., Pan, Y., Liu, Y., Wu, M., Shan, T., Zhu, G., Wu, Q., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128055 · Cited by 2

Machine learning (ML) and deep learning (DL) in vaccine target selection, design, development and characterization

Bhattacharya, M., Chatterjee, S., Das, A., Lee, S., & Chakraborty, C. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128051 · Cited by 2

Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial

Levine, K. S., Blanc, R., Wang, Q., Malca, H., Sekulovich, R. E., Jin, H., Liu, S. N., Verhoeven, C., Sullivan, B. M., Smolenov, I. V., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01431-x · Cited by 4

Platelet-Targeted Self-Amplifying mRNA for Safe, Long-Acting Thromboprophylaxis

Song, Y., Nguyen, T. L., Shi, P., Refaat, A., Pham, C. V., Xu, B., Ren, S., Skoraczynski, J. I., Nguyen, A., Liu, H., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327626 · Cited by 2

Mycobacterium tuberculosis-induced PCBP1 degradation drives macrophage ferroptosis to promote infection: a lung-macrophage-targeted RNAa nanotherapy

Huang, H.-S., Chi, J.-X., Wang, J.-J., Xiao, L.-Y., Chen, L., Lai, S.-Y., Liu, W.-Y., Yang, F., Liao, K.-S., Pi, J., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04569-x · Cited by 2

mRNA Vaccines for Influenza: Hope for a Universal Vaccine?

Omotara, P., Zhu, W., & Wang, B. (2026) · BioDrugs · doi:10.1007/s40259-026-00791-z · Cited by 2

pH modulates the role of SP6 RNA polymerase in transcription process: an in silico study

Singh, S. R., & Murali, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2170916 · Cited by 2

Recent Advances in mRNA Vaccine Development

Aga, A. M., Kelel, M., & Gemeda, M. T. (2023) · Open Access Journal of Microbiology & Biotechnology · doi:10.23880/oajmb-16000275 · Cited by 7

Points-to-consider: the mRNA vaccine reflection paper

Yamaguchi, T., Ogawa, T., Tsuyoshi, A. N. D. O., Yoshida, S., Sakurai, A., Maki, K., & Araki, Y. (2024) · Translational and Regulatory Sciences · doi:10.33611/trs.2023-007 · Cited by 2

A multi-epitope self-amplifying mRNA SARS-CoV-2 vaccine design using a reverse vaccinology approach

Claudia, B., Nugrahapraja, H., & Giri-Rachman, E. A. (2024) · Research in Pharmaceutical Sciences · doi:10.4103/rps.rps_91_23 · Cited by 2

A piezoelectric electroporator (Piezopen) for enhanced “naked” RNA vaccine delivery

Michalaki, E., Zanten, A. V., Najjar, J., & Byagathvalli, G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353214 · Cited by 2

Advancing Protein‐Coding RNA Engineering: From Structural Refinement to Biomedical Implementation

Lu, X., Li, S., Chi, Y., Lin, S., Yuan, H., Lin, Z., Xiao, Y., Yin, H., Zuo, X., Cheng, R., et al. (2025) · Biotechnology Journal · doi:10.1002/biot.70038 · Cited by 2

Africa is an Essential Partner in the Research and Development of an HIV Vaccine

Gray, G., Williamson, C. E., Bekker, L., Daniels, B. B., Smidt, W., Garrett, N., Kityo, C. M., Mwesigwa, B., Stranix‐Chibanda, L., Akimbu, A., et al. (2025) · Current HIV Research · doi:10.2174/011570162x361496250627004203 · Cited by 2

Messenger RNA vaccines in the prevention of allergic diseases

Li, S., Zheng, Y., & Cheng, L. (2025) · World Allergy Organization Journal · doi:10.1016/j.waojou.2025.101150 · Cited by 2

Generation of mRNA Vaccine: An Analysis of Two Types of Vectors

Ohanube, G. A. K., & Obeta, U. M. (2021) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/0nhpnuouhg · Cited by 2

Prophylactic Ribonucleic Acid Vaccines to Combat RNA Viral Infections in Humans

Louis, I. V.-S., & Abadie, J. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108163 · Cited by 3

Technologies for Making New Vaccines

Pecetta, S., Ahmed, S., Ellis, R. W., & Rappuoli, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00067-0 · Cited by 2

Innovation-driven trend shaping COVID-19 vaccine development in China

Zhang, Y., Zhao, Y., Liang, H., Xu, Y. M., Zhou, C., Yao, Y., Wang, H., & Yang, X. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1034-6 · Cited by 2

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien

Monschein, T., Zrzavy, T., Löbermann, M., Winkelmann, A., Berger, T., Rommer, P. S., Hartung, H., & Zettl, U. K. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01154-5 · Cited by 2

Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics

Safford, H. C., Palanki, R., Ang, M. J. Y., & Mitchell, M. J. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00476 · Cited by 2

Secular changes in human reproduction and assisted reproductive technologies

Saniotis, A., & Henneberg, M. (2021) · Anthropological Review · doi:10.2478/anre-2021-0019 · Cited by 1

Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA

Vilpreux, C., Fourquin, P., Martinez, G., Court, M., Appaix, F., Duteyrat, J.-L., Henry, M., Vollaire, J., Ayad, C., Yavuz, A., et al. (2026) · eLife · doi:10.7554/elife.94514.4 · Cited by 1

mRNA-Vaccine Platform: Features of Obtaining and Delivery of mRNA

Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Биоорганическая химия · doi:10.31857/s013234232302015x · Cited by 2

Messenger RNA Lipid-Based Nanoparticles: Optimization of Formulations in the Lab

Delehedde, C., Ciganek, I., Laroui, N., Rameix, N., Perche, F., & Pichon, C. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3770-8_12 · Cited by 1

Design of a self-regulating mRNA gene circuit

Dykeman, E. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-70363-0 · Cited by 1

Evaluation of Tembusu virus single-round infectious particle as vaccine vector in chickens

Huang, Y., Liu, Z., Zhang, J., Dong, J., Li, L., Xiang, Y., Kuang, R., Gao, S., Sun, M., & Liu, Y. (2024) · Veterinary Microbiology · doi:10.1016/j.vetmic.2024.110270 · Cited by 1

The Principle and Derivation of Mrna Vaccine

Wang, C. (2024) · Highlights in Science Engineering and Technology · doi:10.54097/px931970 · Cited by 1

A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication–transcription system

Liu, H.-L., Lin, S., Hung, W., Chang, D. C., & Lin, S.-L. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151654 · Cited by 1

Advancing Eco-friendly Biomedicine: Sustainable Nanocomposites as Platforms for Genetic Vaccines

Hamidi, A., & Poudineh, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-79110-9_11 · Cited by 2

mRNA vaccination facilitates the prevention and control of infectious diseases at an unprecedented speed

Ma, J., Li, M., Xie, Z., & Li, D. (2025) · Decoding Infection and Transmission · doi:10.1016/j.dcit.2025.100048 · Cited by 1

Optimization of In Vitro Transcription by Design of Experiment to Achieve High Self-Amplifying RNA Integrity

Hu, C., Wang, H., Liu, G., Li, K., Zhang, X., Song, L., Gao, F., Xing, W., Wang, Q., Liu, M., et al. (2025) · Vaccines · doi:10.3390/vaccines13101062 · Cited by 1

mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal models

Hazell, N. C., Reyna, R. A., Adam, A., Bonam, S. R., Bei, J., Kumar, N., Nguyen, T., Plante, J. A., Wu, T., Walker, D. H., et al. (2026) · Journal of Virology · doi:10.1128/jvi.01897-25 · Cited by 3

LNP-mRNA vaccines: Revolutionizing preventive medicine

Bhowmik, S., Kundu, S., Ghosh, S., Chowdhury, A. A., & Acharya, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45006-8.00007-0 · Cited by 1

Engineering multiple levels of specificity in an RNA viral vector

Chong, L. S., Kang, J., Ince, M., Kim, M. S., Gao, X. J., & Elowitz, M. B. (2026) · Nature Communications · doi:10.1038/s41467-026-71033-7 · Cited by 5

From edits to Circuits: Nucleic acid therapeutics for Correcting human disease

Guinn, M. T., Sinenko, I., Ghanta, R. K., & Omid Veiseh, A. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103351 · Cited by 1

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA

Zhou, S., Wang, Z., Xu, Y., Meng, T., Barrett, S., & Zhu, G. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00671 · Cited by 1

Recent progress in the rational design of mRNA vaccines

Guo, Z., Fu, J., Ran, L., Bao, N., Wang, Y., Dong, H., Yang, X., & Jin, Y. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.020 · Cited by 1

Bridging the vaccine gap: Scientific and technological advances for diseases lacking effective vaccines

Ikrar, T., Muchsin, W., & Sophian, A. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106487 · Cited by 1

Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases

Cai, D., Li, X., Wang, R., Chen, L., Wen, J., & Tian, B. (2026) · Vaccines · doi:10.3390/vaccines14090781 · Cited by 1

Introduction

Mueller, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-18903-6_1 · Cited by 1

Engineering a Synthetic RNA Segregation System

Hürtgen, D., Mascarenhas, J., Vibhute, M. A., Weise, L. I., Mayr, V., Sourjik, V., & Mutschler, H. (2023) · ChemSystemsChem · doi:10.1002/syst.202200028 · Cited by 1

A New Era of RNA Personalized Vaccines for Cancer and Cancer-Causing Infectious Diseases

Pazzi, A. A., Vij, P., Salhadar, N., George, E., & Tripathi, M. K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110905 · Cited by 1

Immune Profile Determines Response to Vaccination against COVID-19 in Kidney Transplant Recipients

Stai, S., Fylaktou, A., Kasimatis, E., Xochelli, A., Λιούλιος, Γ., Nikolaidou, V., Παπαδοπούλου, Α., Myserlis, G., Iosifidou, A. M., Iosifidou, M. A., et al. (2023) · Vaccines · doi:10.3390/vaccines11101583 · Cited by 1

Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2

Fylaktou, A., Stai, S., Kasimatis, E., Xochelli, A., Nikolaidou, V., Παπαδοπούλου, Α., Myserlis, G., Λιούλιος, Γ., Asouchidou, D., Giannaki, M., et al. (2023) · Vaccines · doi:10.3390/vaccines11111670 · Cited by 1

A Comprehensive Review of the Status and Challenges in the Genesis of COVID 19 Vaccination Strategies

Banerjee, M., Chadha, S., Sanyal, S., & Mukherjee, S. (2023) · Coronaviruses · doi:10.2174/0126667975269506231108053010 · Cited by 1

Oligonucleotides and mRNA Therapeutics

Blenke, E. O., Schiffelers, R. M., & Mastrobattista, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-30023-3_13 · Cited by 1

Liposomes as vaccine delivery systems

Wang, N., Liu, X., Ma, X., & Wang, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00009-2 · Cited by 2

Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication

Han, H.-J., Yu, D., Yu, J., Kim, J., Heo, W. D., Tark, D., & Kang, S. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002071 · Cited by 1

Comparative Function Analysis of Self‐Amplifying mRNA and Self‐Amplifying DNA

Li, W., Wang, Y., Wang, C., Huo, Y., & Lu, Y. (2025) · ChemBioChem · doi:10.1002/cbic.202500110 · Cited by 1

Vaccines against COVID-19 – Catching the Rays of Hope

Srinivasamurthy, S. K., & Bairy, L. K. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i47a33035 · Cited by 1

SARS CoV-2 adenovirus and RNA based vaccines potential autoimmune complications: could we lower the chances?Preprint

Kelleni, M. T. (2021) · doi:10.22541/au.160677062.20686503/v3 · Cited by 1

Ultra-compacted single self-amplifying RNA molecules as quintessential vaccinesPreprint

Herrero, J. M., Stahl, T. B., Erbar, S., Maxeiner, K., Schlegel, A., Bacic, T., Cavalcanti, L. P., Schroer, M. A., Svergun, D. I., Şahin, U., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2142761/v1 · Cited by 1

Vaccinations in pregnancy against TORCH pathogens

Beharier, O., & Neeman, M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.010 · Cited by 1

Sperm fertility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNAPreprint

Vilpreux, C., Martinez, G., Fourquin, P., Court, M., Appaix, F., Duteyrat, J.-L., Henry, M., Vollaire, J., Ayad, C., Yavuz, A., et al. (2025) · eLife · doi:10.7554/elife.94514.2 · Cited by 1

Genetically Modified Viral Vectors for Vaccine Delivery

Arora, D., Taneja, Y., Gulati, D., Kumar, M., Pareek, A., & Gautam, R. K. (2025) · Wiley eBooks · doi:10.1002/9781394271566.ch6 · Cited by 1

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development

Schmidt, C., & Schnierle, B. S. (2023) · Pathogens · doi:10.3390/pathogens12010138 · Cited by 78

Perspective Chapter: Next-Generation Vaccines Based on Self-Amplifying RNA

Nafian, F., Nafian, S., Soleymani, G., Pourmanouchehri, Z., Kiyanjam, M., Jalaei, S. B., Jeyroudi, H., & Mohammdi, S. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101467 · Cited by 2

The advent of clinical self-amplifying RNA vaccines

Casmil, I. C., Jin, J., Won, E.-J., Huang, C., Liao, S., Cha‐Molstad, H., & Blakney, A. K. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.060 · Cited by 111

The Potential of Self-amplifying RNA Vaccines for Infectious Diseases and COVID-19

Lundstrom, K. H., & PanTherapeutics (2020) · Vaccine Research · doi:10.29252/vacres.7.1.25 · Cited by 10

RNA-Based Vaccines for Infectious Disease

Dehari, D., Chaudhuri, A., Singh, S., & Agrawal, A. K. (2022) · CRC Press eBooks · doi:10.1201/9781003186069-7 · Cited by 5